Recent Articles

  • Posts not found

Familial RUNX1 Grant Program

ALSF is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers. The RUNX1 Research Program (runx1.com) is dedicated to advancing areas of research of particular importance to families affected by familial platelet disorders (FPDs) leading to acute myeloid leukemia (AML) due to germline RUNX1 mutations with the ultimate goal of developing effective therapies to prevent the onset of AML.

Application Deadlines: December 26, 2019

More Information

GCO Funding Opportunities

Monthly and continuous submission funding opportunity packets are available on the GCO Funding Opportunities web page.